{
    "nct_id": "NCT02295059",
    "official_title": "Omega-3 Fatty Acids and ERPR(-) and HER-2/Neu(+/-) Breast Cancer Prevention",
    "inclusion_criteria": "* Prior diagnosis of Stage 0 to III breast cancer that is estrogen receptor negative, progesterone receptor negative with completion of definitive surgery, radiation therapy and/or chemotherapy.\n* Completion of chemotherapy or trastuzumab for > six months and of radiation therapy for > 2 months, as applicable and 5 years or less from completion of standard therapy.\n* Greater than 1 year from pregnancy, lactation.\n* Mammogram within the eight months prior to study enrollment that is not suspicious for breast cancer (ACR Class I-III).\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Other current malignancy or metastatic malignancy of any kind.\n* Ongoing chemotherapy, radiation therapy, or other cancer-related treatment.\n* Subjects on Coumadin or other anticoagulants.\n* Subjects with breast implants.\n* Subjects who have had radiation to both breasts or who have undergone bilateral mastectomies.\n* Barriers to fine needle aspiration sampling of breast adipose tissue and/or parenchymal breast tissue, including breast implants, history of radiation to both breasts, bilateral mastectomies, and/or insufficient breast adipose/parenchymal tissue for adequate fine needle aspiration (FNA) sampling.\n* Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, hypertension, or psychiatric illness/social situation that would limit compliance with study requirements.\n* Chronic use of omega 3 fatty acid concentrates or capsules within the 3 months prior to entry on the study or any other supplements that might interact with omega 3 fatty acid supplements.\n* Pregnant or nursing women.\n* Known sensitivity or allergy to fish.\n* Subjects on a standing regimen of full dose aspirin (greater than 325 mg/day), NSAIDs (nonsteriodal anti inflammatory drug) or NSAID-containing products.",
    "miscellaneous_criteria": ""
}